Related Experiment Video
Updated: Oct 7, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Effect of Expanded Hemodialysis with Theranova® in Patients with COVID-19
María Luisa Serrano Salazar1, Jose Portolés1,2, Maria de Valdenebro Recio1
1Nephrology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
Insights
Expanded hemodialysis (HDx) shows promise in managing severe COVID-19 patients requiring renal replacement therapy (RRT). HDx demonstrated superior cytokine and beta-2 microglobulin clearance, alongside reduced mortality compared to online hemodiafiltration (OL-HDF).
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- Severe COVID-19 can trigger cytokine storms, necessitating immunosuppressive treatment.
- Renal replacement therapy (RRT) offers a potential avenue for cytokine removal in COVID-19 patients with kidney injury.
- Understanding the efficacy of different RRT techniques in managing cytokine profiles is crucial for improving patient outcomes.
Purpose of the Study:
- To compare the effectiveness of online hemodiafiltration (OL-HDF) and expanded hemodialysis (HDx) in managing cytokine levels in COVID-19 patients requiring RRT.
- To evaluate the impact of these RRT techniques on beta-2 microglobulin and albumin levels.
- To assess the mortality rates associated with OL-HDF and HDx in this patient population.
Main Methods:
- A prospective observational study involving 26 patients (18 COVID-19 on RRT, 8 controls).
- COVID-19 patients on RRT were assigned to either OL-HDF or HDx based on Brescia group recommendations.
- Cytokine, beta-2 microglobulin, and albumin levels were measured pre/post-dialysis and at 1-2 weeks, with comparisons made between techniques and a control group.
Main Results:
- COVID-19 patients exhibited higher cytokine levels than controls, with those having acute kidney injury (AKI) showing even higher levels.
- HDx demonstrated superior clearance of TNF-alpha and beta-2 microglobulin compared to OL-HDF.
- Mortality rates were higher in the OL-HDF group than in the HDx group.
Conclusions:
- HDx appears to be a safer and more effective RRT technique for COVID-19 patients with RRT requirements, offering better cytokine and beta-2 microglobulin clearance.
- While not statistically significant due to sample size, preliminary data suggest HDx may reduce AKI incidence.
- Further research is warranted, but HDx presents a promising approach for managing critically ill COVID-19 patients during current and future viral pandemics.
Introduction:
Cytokine storm control is the main target for improving severe COVID-19 by using immunosuppressive treatment. Effective renal replacement therapy (RRT) could give us an advantage removing cytokines in patients with RRT requirements superimposed on COVID-19.
Methods:
This is a prospective observational study in COVID-19 patients who required hemodialysis (HD). Patients were assigned to online hemodiafiltration (OL-HDF) and expanded HD (HDx) according to Brescia group recommendations. We measured several cytokines, β2 microglobulin and albumin levels pre/post-dialysis and on 1st-2nd week. We compared levels among both techniques and control group (HD without COVID-19).
Results:
We included 26 patients: 18 with COVID-19 on RRT (5 of them had acute kidney injury [AKI]) and 8 controls. We confirm higher cytokine levels in COVID-19 patients than controls and even higher in patients with AKI than in those with chronic kidney disease. Most cytokines raised during HD session, except IL-10 and TNFα. IL-10 was eliminated by any dialysis technique, while clearance of TNFα was higher in the HDx group. HDx achieved a deeper normalization of cytokines and β2 microglobulin reduction. Mortality was higher in the OL-HDF group than the HDx group.
Discussion:
Not all cytokines behave equally along HD session. The following characteristics should be taken into account, such as intrinsic kinetic profile during a HD session. HDx seems to get better performance, probably due to the combination of different factors; however, we did not reach statistical significance due to the small sample size, dropout, and reduction of AKI incidence during the 2nd pandemic wave.
Conclusion:
HDx appears to provide better clearance for TNFα and β2 microglobulin during HD session and associates lower mortality. We propose the HDx technique for COVID-19 patients with RRT requirements since it seems to be safe and more effective than OL-HDF. Further studies are still needed, but we hope that our preliminary data may help us in future pandemic waves of SARS-CoV-2 or other viruses still to come.
More Related Videos
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Hemodialysis I: Introduction
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Dialysis
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

